Ftse Mib
34.193,96
-0,30%
DAX
18.050,49
-0,45%
S&P 500
5.116,17
0,32%
NASDAQ Composite
15.983,08
0,35%
Bitcoin
61.835,04
-3,14%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Quanterix Corporation (QTRX) Quanterix Corporation (QTRX) Notizie

Quanterix Corporation

QTRX
15,58
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:09:57
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/4/202422:00BWQuanterix To Report First Quarter 2024 Financial Results
21/3/202422:30BWQuanterix Outlines Partner Path With Labs to Expedite..
04/3/202423:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:00BWQuanterix Granted Breakthrough Device Designation from U.S...
29/2/202422:58EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:00BWQuanterix Releases Operating Results for Fourth Quarter and..
27/2/202400:58BWQuanterix Reschedules Q4 and Full Year 2023 Earnings..
26/2/202415:00BWQuanterix Announces First Collaborations with Five Health..
23/2/202422:30BWQuanterix to Present at Cowen’s 44th Annual Health Care..
16/2/202422:00BWQuanterix Fourth Quarter Earnings and Full Year 2023..
15/2/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202422:05EDGAR2Form 8-K - Current report
04/1/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202423:21EDGAR2Form 144 - Report of proposed sale of securities
12/12/202322:00BWQuanterix to Present at 42nd Annual J.P. Morgan Healthcare..
01/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:00BWQuanterix To Participate at The Canaccord Genuity MedTech,..
13/11/202313:00GLOBESotera Health Appoints Karen Flynn to Board of Directors
06/11/202323:56BWQuanterix Releases Operating Results for Third Quarter 2023
06/11/202323:03EDGAR2Form 8-K - Current report
06/11/202322:50BWQuanterix Releases Operating Results for Third Quarter 202
01/11/202314:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:00BWQuanterix to Report Third Quarter 2023 Financial Results on..
24/10/202322:30BWQuanterix Launches High Accuracy p-Tau 217 Blood Biomarker..
24/10/202302:30BWQuanterix Announces New Agreement to Advance Blood Based..
02/10/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202323:00BWQuanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease..
06/9/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202314:00BWQuanterix to Participate at the Morgan Stanley 21st Annual..
22/8/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202322:02EDGAR2Form 8-K - Current report
21/8/202322:30BWWilliam P. Donnelly Appointed to Quanterix’s Board of..
09/8/202314:52EDGAR2Form 8-K - Current report
09/8/202314:30BWQuanterix Appoints Vandana Sriram as Chief Financial Officer
08/8/202316:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202323:21EDGAR2Form 8-K - Current report
07/8/202323:13BWQuanterix Releases Operating Results for Second Quarter 2023
03/8/202314:00BWQuanterix to Present at Canaccord Genuity 43rd Annual Growth..
02/8/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202314:00BWQuanterix’s Simoa® Technology Powers Large, International..
20/7/202314:00BWQuanterix to Report Second Quarter 2023 Financial Results on..
06/7/202323:37BWQuanterix Launches LucentAD Biomarker Blood Test to Aid..
05/7/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202322:00BWQuanterix to Participate in Fireside Chat at Goldman Sachs..
Apertura: Min: Max:
Chiusura: 15,58

La tua Cronologia

NASDAQ
QTRX
Quanterix
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network